Open Access
Subscription Access
Important Parameters of Bromazepam Include Medical Uses, Pharmacokinetics, Side-Effects, Overdose, Contraindications, Interactions, Drug Misuse and Brand Name
Abstract
Bromazepam, sold under many brand names, is a benzodiazepine. It is primarily an anti-anxiety agent along with similar side effects to diazepam. In addition to being used to treat anxiety or panic states, bromazepam may also be utilized as a premedicant prior to minor surgery. Bromazepam is available in doses of 1.5 mg, 3 mg and 6 mg tablets. It was patented in 1961 by Roche and approved for medical use in 1974.
References
Bromazepam: Uses, Interactions, Mechanism of Action &; Drug Bank Online. Retrieved 25 February 2024.
Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025 (pdf). Therapeutic Goods Administration (TGA). May 2025. Retrieved 31 August 2025.
Anvisa (31 March 2023). & RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas,Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists ofNarcotic, Psychotropic, Precursor, and Other Substances under Special Control] (inBrazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
Lexotan (bromazepam) Product Insert (PDF). Roche. 23 October 2012.
Bromazepam". Pharmaceutical Benefits Scheme (PBS). Australian Government -Department of Health. Retrieved 23 March 2014.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons.
p. 53X. ISBN 9783527607495.
Content Not Available". www.uptodate.com. Retrieved 7 September 2017.
Podiwinsky F, Jellinger K (March 1979). Bromazepam in the treatment of somatized psychogenic disorders (author' transl)] [Bromazepam in the treatment of somatized psychogenic disorders]. Wiener Klinische Wochenschrift (in
German). 91 (7): 240–244. PMID 34934.
Laxenaire M, Kahn JP, Marchand P (May 1982). A clinical trial of bromazepam (author& transl)]" [A clinical trial of bromazepam]. La Nouvelle Presse Médicale (in
French). 11 (22): 1699–1701. PMID 6124936.
Ropert R, Bernes J, Dachary JM (1987). Efficacy and tolerance of alprazolam and
bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients]&
[Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study
in 119 ambulatory anxious patients]. L&Encéphale (in French). 13 (2): 89–95. PMID 2885173.
Hallett C, Dean BC (11 August 2008). "Bromazepam: acute benefit-risk assessment in general practice". Current Medical Research and Opinion. 8 (10): 683–688. doi:10.1185/03007998409110117. PMID 6144455.
Bromazépam (PDF). Haute Autorité de santé (HAS) (in French). 7 September
Bromazepam
Notes when using Bromazepam to treat insomnia". Vinmec. Retrieved 28 September 2025.
Bromazépam". Répertoire des Spécialités Pharmaceutiques. ANSM: Agence Nationale de Sécurité du Médicament et des Produits de Santé (French: National Security Agency of Medicines and Health Products).
Chweh AY, Lin YB, Swinyard EA (April 1984). "Hypnotic action of benzodiazepines: a possible mechanism". Life Sciences. 34 (18): 1763–1768. doi:10.1016/0024-3205(84)90576-9. PMID 6145073.
Cordingley GJ, Dean BC, Hallett C (11 August 2008). "A multi-centre, double-blind parallel trial of bromazepam ('Lexotan') and lorazepam to compare the acute benefit-risk ratio in the treatment of patients with anxiety". Current Medical Research and Opinion. 9 (7): 505–510. doi:10.1185/03007998509109625. PMID 2863089.
Braestrup C, Squires RF (April 1978). "Pharmacological characterization of benzodiazepine receptors in the brain". European Journal of
Pharmacology. 48 (3): 263–270. doi:10.1016/0014-2999(78)90085-7. PMID 639854.
Bromazepam Eutimia.com - Salud Mental. © 1999-2002.Research and Reviews: Journal of Forensic NursingVolume 4 Issue 1, Jan - Jun 2026 e-ISSN:3048-5517
Poisbeau P, Gazzo G, Calvel L (11 September 2018). "Anxiolytics targeting
GABA A receptors: Insights on etifoxine". The World Journal of Biological
Psychiatry. 19 (sup1): S36–S45. doi:10.1080/15622975.2018.1468030. PMID 30204559.
Refbacks
- There are currently no refbacks.